(Q37857261)

24 August 2017

1 reference

title

The cyclins: a family of widely expressed tumor antigens? (English)

1 reference

Michael von Bergwelt-Baildon

24 August 2017

author

series ordinal

1

object named as

Michael S von Bergwelt-Baildon

1 reference

24 August 2017

Eisei Kondo

2

1 reference

24 August 2017

Nela Klein-González

series ordinal

3

1 reference

24 August 2017

Clemens M Wendtner

series ordinal

4

1 reference

24 August 2017

publication date

1 March 2011

1 reference

Expert Review of Vaccines

24 August 2017

published in

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

389-395

1 reference

Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cell cycle as a target of antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Adoptive cell therapy for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Wt1 Peptide Vaccine, one of the most Promising Cancer Vaccines: Its Present Status and the Future Prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Using CD40-activated B cells to efficiently identify epitopes of tumor antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Overexpression of cyclin B1 in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

NF-Y-dependent cyclin B2 expression in colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D1 expression is regulated by the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D1 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D1 overexpression in malignant lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

E- and A-type cyclins as markers for cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

HPV vaccination for the prevention of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

Varicella-zoster virus infection of human foreskin fibroblast cells results in atypical cyclin expression and cyclin-dependent kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.170

21 January 2018

Identifiers

DOI

10.1586/ERV.10.170

1 reference

24 August 2017

1 reference